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treatment modality were identified. The average technical success rate was
94% and the procedure-related complication rate was 14.7%. The weighted
mean cumulative primary patency rates were 60%, 57% and 35% at 1, 2 and
5 years, respectively. The weighted mean assisted primary patency rates were
75%, 77% and 50% at 1, 2 and 5 years, respectively. The weighted mean
secondary patency rates were 88% and 62% at 1 and 2 years, respectively.
Conclusions: RSFAE has acceptable short-, medium- and long-term
results but patients should undergo intensive surveillance postoperatively.
Randomized controlled trials are needed to assess the durability of this
procedure as compared to conventional open bypass surgery.
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Objective: To evaluate the efficacy of peripheral angioplasty (PTA) in
the treatment of diabetic patients with previous peripheral bypass graft and
recurrent critical limb ischemia (CLI).
Methods: Between January andDecember 2006, 293 diabetic patients
presenting with critical limb ischemia (CLI) according to the TASC 2000
criteria were admitted to our footcare centre. Among these patients, 32 of
them had previously undergone bypass grafting: femoropopliteal in 26
patients, femoroposterior tibial in 3 patients, femoroperoneal in the remain-
ing 3. All these patients underwent angiography and, whenever possible, a
concomitant PTA procedure.
Results: Six patients presented with stenosis at the distal anastomosis,
2 with stenosis at the proximal anastomosis and in 5 patients both the distal
and proximal anastomosis were stenosed. In 12 patients the graft was
completely occluded. In 7 patients the graft appeared patent but all the
infrapopliteal arteries were occluded. The average time interval between
bypass and subsequent hospital admission because of CLI was 6.3  4.2
months for patients with patent grafts and 20.5  12.0 months for those
with failing grafts (p  0.004).
A successful PTA was performed in 25 patients (78.1%). In all patients
with patent grafts, PTA recanalized one infrapopliteal artery. Recanalization
of the graft was obtained in all 13 patients with non-occluded graft.
Recanalization of superficial femoral artery occlusion by means of PTA was
obtained in 5 out of the 12 patients in whom the graft was completely
occluded. Five patients underwent major amputation within 30 days and 3
further patients during the follow-up period. Patients were followed up until
December 31 2007, with a mean follow-up of 1.89  0.27 years. Restenosis
occurred in 7 (28.0%) of the 25 patients in whom a successful PTA was
performed. In 5 of these 7 patients, PTA was repeated successfully. In 2
patients in whom a further PTA was not feasible a major amputation was
performed. At the end of the follow-up period the cumulative primary
patency rate was 72%, the assisted patency rate was 92%.
Conclusions: PTA is an effective method for revascularizing secondary
obstructions in patients with graft failure (and no possibility of a redo graft).
PTA also is effective in at least one subgenicular artery in patients with
diabetes with inadequate run-off after femoropopliteal bypass grafting.
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Background: This study aimed to review the literature regarding
fracture of arterial stents, especially its relation to location of placement,
clinical relevance, and type of stents.
Material and methods:We searched published articles in PubMed up
to February 2008 by using the terms: stent fracture or stent breakage.
Results: Thirty-one articles met our inclusion and exclusion criteria.
Most of the studies reported fractures in stents placed in the superficial
femoral artery or popliteal arteries. The cumulative incidence of stent
fractures ranged from 2% to 65%, i.e. 0.6 to 60 per 1000 person-months.
Stent fractures occur more frequently in the superficial femoral artery and
are common when multiple stents are deployed and overlap. Stent
fractures are associated with a higher risk of in–stent restenosis and
re-occlusion.
Conclusion: The incidence of stent fracture, its location of placement,
and type of stent used were diverse across studies. Stent fracture may cause
clinical deterioration especially in the femoropopliteal segment, and it
should be detected before clinical manifestation appears. Further studies
with larger study population involving new type of stents for a longer follow
up period are warranted.
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Background: To study the long-term patency of thrombosed pros-
thetic vascular access grafts treated with percutaneous mechanical throm-
bectomy (PMT) followed by aggressive surveillance and monitoring and
repeated endovascular interventions.
Study design:Two hundred seven vascular access grafts presented with
first-time thrombosis were treated with PMT using the AngioJet device
(n  185) or the Arrow-Trerotola percutaneous thrombolytic device
(n  22) followed by angioplasty ( stenting) of the anatomical lesion
responsible for the thrombotic event. Clinical success was considered at least
one successful subsequent hemodialysis session. Graft surveillance/monitor-
ing included clinical and hemodialysis parameters to detect a failing or
thrombosed graft.
Results: PMT was technically successful in 202 cases (97.6%) and
clinically successful in 193 cases (93.2%). During follow-up, 149 got throm-
bosed and either abandoned (n  33) or underwent at least once repeat
thrombectomy (n  116); finally 100 grafts were abandoned (n  90),
ligated (n  5) or removed (n  5). Endovascular management (0.54 pro-
cedures per 100 graft-days, thrombectomy, n  307 sessions and angio-
plasty, n  162 sessions) increased significantly functional assisted-primary
patency rates from 29% and 14% at 1 and 2 years to a secondary patency of
62% and 47%, respectively. Secondary patency was worse in loop grafts
(P  .02) and intermediate graft thrombosis (occurred between 31–182
days after graft placement, P  .001) and better when renal failure was due
to hypertension or diabetes (compared to other or cryptogenic causes,
P  .048) or isolated angioplasty for graft dysfunction during follow-up had
been performed (P  .001). Multivariate analysis identified intermediate
graft thrombosis and isolated angioplasty as independent predictors of
secondary patency (P  .001, relative risk 2.77 and P  .001, relative risk
0.28, respectively).
Conclusions: PMT is a highly successful procedure with acceptable
long-term secondary patency results, provided that aggressive endovascular
management of subsequent thrombotic or dysfunction episode is per-
formed. Further research to identify the causes of intermediate graft throm-
bosis is justified.
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